Compositions and methods for producing podophyllotoxin derivatives

US2017088872A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017088872-A1
Application numberUS-201615242525-A
CountryUS
Kind codeA1
Filing dateAug 20, 2016
Priority dateAug 21, 2015
Publication dateMar 30, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides compositions and methods for biosynthetically producing podophyllotoxin intermediates and derivatives including enzymes and their equivalents involved in the biosynthetic production of podophyllotoxin intermediates and derivatives.

First claim

Opening claim text (preview).

What is claimed is: 1 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:1, and conservative variants thereof. 2 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:2, and conservative variants thereof. 3 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:3, and conservative variants thereof. 4 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:4, and conservative variants thereof. 5 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:5, and conservative variants thereof. 6 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:6, and conservative variants thereof. An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:7, and conservative variants thereof. 8 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:8, and conservative variants thereof. 9 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:9, and conservative variants thereof. 10 . An isolated nucleic acid molecule encoding an enzyme involved in synthesizing podophyllotoxin intermediates and derivatives and having at least 90% sequence identity to nucleic acid SEQ ID NO:10, and conservative variants thereof. 11 . A vector comprising one or more of the nucleic acid molecules according to any of claims 1 - 10 , wherein said one or more nucleic acid molecule is operably linked to a nucleic acid molecule comprising a promoter sequence, conferring expression of one or more enzymes involved in synthesizing podophyllotoxin intermediates and derivatives. 12 . A host cell comprising one or more of the nucleic acid molecules according to any of claims 1 - 10 for use in expressing enzymes involved in synthesizing podophyllotoxin intermediates and derivatives. 13 . A host cell for producing 4′-desmethylepipodophyllotoxin, comprising nucleic acid SEQ ID NO:1 for converting pinoresinol to secoisolariciresinol; nucleic acid SEQ ID NO:2 for converting secoisolariciresinol to matairesinol; nucleic acid SEQ ID NO:3 for converting matairesinol to pluviatolide; nucleic acid SEQ ID NO:4 for converting pluviatolide to 5′-desmethoxy-yatein; nucleic acid SEQ ID NO:5 for converting 5′-desmethoxy-yatein into 5′-desmethyl-yatein; nucleic acid SEQ ID NO:6 for converting 5′-desmethyl-yatein into yatein; nucleic acid SEQ ID NO:7 for converting yatein into deoxypodophyllotoxin; nucleic acid SEQ ID NO:8 for converting deoxypodophyllotoxin into 4′-desmethyl-deoxypodophyllotoxin; and nucleic acid SEQ ID NO:9 for converting 4′-desmethyl-deoxypodophyllotoxin into 4′-desmethyl-epipodophyllotoxin. 14 . The host cell of claim 12 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 15 . The host cell of claim 13 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 16 . The host cell of claim 13 , furthermore comprising nucleic acid SEQ ID NO:10 or a conservative variant thereof. 17 . The host cell of claim 14 , wherein the plant cell is Nicotiana benthamiana. 18 . The host cell of claim 15 , wherein the plant cell is Nicotiana benthamiana. 19 . A method for producing a podophyllotoxin intermediate and derivative in a host cell, comprising culturing and transforming the host cell with one or more of the nucleic acid molecules according to any of claims 1 - 10 , adding starting material suitable to produce the podophyllotoxin intermediate and derivative to culture medium; and recovering the podophyllotin intermediate and derivative from culture medium. 20 . The method of claim 19 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 21 . A method for producing 4′-desmethyl-epipodophyllotoxin in a host cell, comprising culturing and transforming the host cell with nucleic acid SEQ ID NO:1 for converting pinoresinol to secoisolariciresinol; nucleic acid SEQ ID NO:2 for converting secoisolariciresinol to matairesinol; nucleic acid SEQ ID NO:3 for converting matairesinol to pluviatolide; nucleic acid SEQ ID NO:4 for converting pluviatolide to 5′-desmethoxy-yatein; nucleic acid SEQ ID NO:5 for converting 5′-desmethoxy-yatein into 5′-desmethyl-yatein; nucleic acid SEQ ID NO:6 for converting 5′-desmethyl-yatein into yatein; nucleic acid SEQ ID NO:7 for converting yatein into deoxypodophyllotoxin; nucleic acid SEQ ID NO:8 for converting deoxypodophyllotoxin into 4′-desmethyl-deoxypodophyllotoxin; and nucleic acid SEQ ID NO:9 for converting 4′-desmethyl-deoxypodophyllotoxin into 4′-desmethyl-epipodophyllotoxin; adding pinoresinol as starting material to culture medium; and recovering 4′-desmethylepipodophyllotoxin from culture medium. 22 . The method of claim 21 , wherein the host cell is a plant, yeast, bacterial, insect or mammalian cell. 23 . The method of claim 21 , wherein the host cell furthermore comprises nucleic acid SEQ ID NO:10 or a conservative variant thereof.

Assignees

Inventors

Classifications

  • Methyltransferases (2.1.1) · CPC title

  • Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin · CPC title

  • acting on the CH-CH group of donors (1.3) · CPC title

  • Flavone 3'-O-methyltransferase (2.1.1.42) · CPC title

  • with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017088872A1 cover?
The present invention provides compositions and methods for biosynthetically producing podophyllotoxin intermediates and derivatives including enzymes and their equivalents involved in the biosynthetic production of podophyllotoxin intermediates and derivatives.
Who is the assignee on this patent?
Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification C12N9/1007. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Mar 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).